Life Sciences
Cramer OK's OncoCyte as a Speculative Play. What Do the Charts Say?
Here's how to approach the diagnostics company for both the aggressive and timid.
Our Technical Strategy for Speculative Anavex Life Sciences
Let's check the charts and indicators.
BNGO! Looks Like Bionano Genomics Could Be a Winner
Here's why the current weakness in Bionano Genomics could be a buying opportunity.
Jobs Hold the Key, Premature Minimum Tax Celebration, and Enough Is Enough, Fed
Plus, the latest monthly ISM Manufacturing survey sends a disturbing signal about prices and a quick option play thought about Veeva Systems.
Intellia Therapeutics Busts Out of Resistance on Positive Trial News
The news sent shares of the genome editing company skyward after the stock had been basing for months.
Piecing Together a Portfolio of Lovable Losers Could Be Tough This December
The early potential candidates for the next Tax Loss Selling Recovery Portfolio are few and far between.
The Johnson & Johnson Charts Are Healthy Enough for Further Gains
Here's where traders could probe the long side of JNJ.
PerkinElmer Should Continue Its Rally to Record Highs in the Months Ahead
Traders should approach PKI from the long side at current levels.
AstraZeneca Is Moving the Needle
This drugmaker is making a historic upside breakout. Let's check the charts.
Surgical Device Maker Stryker Is Waiting to Move Higher
Let's review the charts and indicators.